PAI
MEDP icon

Pittenger & Anderson Inc’s Medpace MEDP Stock Holding History

Pittenger & Anderson Inc’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Buy
357
+155
+77% +$71.5K 0.01% 238
2026
Q1 		$97K Sell
202
-1,574
-89% -$806K ﹤0.01% 272
2025
Q4 		$997K Buy
+1,776
New +$1.01M 0.04% 170
2024
Q4 		– Sell
-552
Closed -$184K – 455
2024
Q3 		$184K Buy
552
+295
+115% +$112K 0.01% 235
2024
Q2 		$106K Buy
+257
New +$102K ﹤0.01% 261

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Pittenger & Anderson Inc's MEDP Position: Q2 2026 in Review

Pittenger & Anderson Inc increased its Medpace (MEDP) stake by 77% in Q2 2026, buying an estimated $71.5K and bringing the position to 357 shares worth $189K. The position accounts for 0.01% of the portfolio, ranked #238.

Pittenger & Anderson Inc first reported a position in MEDP in Q2 2024 and has held it in 5 quarters since. The position peaked at $997K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Pittenger & Anderson Inc held 357 shares of Medpace worth $189K as of Q2 2026.
  • Pittenger & Anderson Inc bought 155 Medpace shares in Q2 2026, an estimated $71.5K.
  • Medpace made up 0.01% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #238 holding.
  • Pittenger & Anderson Inc first reported a position in Medpace in Q2 2024 and has held it in 5 quarters since.
  • Pittenger & Anderson Inc's Medpace position peaked at $997K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.